228 related articles for article (PubMed ID: 8490621)
1. Is the maintainance of the C-terminus domain of dystrophin enough to ensure a milder Becker muscular dystrophy phenotype?
Vainzof M; Takata RI; Passos-Bueno MR; Pavanello RC; Zatz M
Hum Mol Genet; 1993 Jan; 2(1):39-42. PubMed ID: 8490621
[TBL] [Abstract][Full Text] [Related]
2. Dystrophin as a diagnostic marker in Duchenne and Becker muscular dystrophy. Correlation of immunofluorescence and western blot.
Voit T; Stuettgen P; Cremer M; Goebel HH
Neuropediatrics; 1991 Aug; 22(3):152-62. PubMed ID: 1944822
[TBL] [Abstract][Full Text] [Related]
3. A homologue of dystrophin is expressed at the blood vessel membrane of DMD and BMD patients: immunological evidence.
Augier N; Boucraut J; Léger J; Anoal M; Nicholson LV; Voelkel MA; Léger JJ; Pellissier JF
J Neurol Sci; 1992 Feb; 107(2):233-8. PubMed ID: 1564523
[TBL] [Abstract][Full Text] [Related]
4. Prediction of dystrophin phenotype by DNA analysis in Duchenne/Becker muscular dystrophy.
Specht LA; Beggs AH; Korf B; Kunkel LM; Shapiro F
Pediatr Neurol; 1992; 8(6):432-6. PubMed ID: 1476571
[TBL] [Abstract][Full Text] [Related]
5. Preservation of the C-terminus of dystrophin molecule in the skeletal muscle from Becker muscular dystrophy.
Arahata K; Beggs AH; Honda H; Ito S; Ishiura S; Tsukahara T; Ishiguro T; Eguchi C; Orimo S; Arikawa E
J Neurol Sci; 1991 Feb; 101(2):148-56. PubMed ID: 2033400
[TBL] [Abstract][Full Text] [Related]
6. Dystrophin or a "related protein" in Duchenne muscular dystrophy?
Nicholson LV; Johnson MA; Davison K; O'Donnell E; Falkous G; Barron M; Harris JB
Acta Neurol Scand; 1992 Jul; 86(1):8-14. PubMed ID: 1519480
[TBL] [Abstract][Full Text] [Related]
7. Large in-frame deletions of the rod-shaped domain of the dystrophin gene resulting in severe phenotype.
Nevo Y; Muntoni F; Sewry C; Legum C; Kutai M; Harel S; Dubowitz V
Isr Med Assoc J; 2003 Feb; 5(2):94-7. PubMed ID: 12674656
[TBL] [Abstract][Full Text] [Related]
8. Deletions in the dystrophin gene: analysis of Duchenne and Becker muscular dystrophy patients in Quebec.
Simard LR; Gingras F; Delvoye N; Vanasse M; Melançon SB; Labuda D
Hum Genet; 1992 Jun; 89(4):419-24. PubMed ID: 1618490
[TBL] [Abstract][Full Text] [Related]
9. Characterization of translational frame exception patients in Duchenne/Becker muscular dystrophy.
Winnard AV; Klein CJ; Coovert DD; Prior T; Papp A; Snyder P; Bulman DE; Ray PN; McAndrew P; King W
Hum Mol Genet; 1993 Jun; 2(6):737-44. PubMed ID: 8353493
[TBL] [Abstract][Full Text] [Related]
10. Differentiation of Duchenne and Becker muscular dystrophy phenotypes with amino- and carboxy-terminal antisera specific for dystrophin.
Bulman DE; Murphy EG; Zubrzycka-Gaarn EE; Worton RG; Ray PN
Am J Hum Genet; 1991 Feb; 48(2):295-304. PubMed ID: 1990838
[TBL] [Abstract][Full Text] [Related]
11. Phenotypic Duchenne muscular dystrophy with C-terminal domain.
Higuchi I; Fukunaga H; Usuki F; Moritoyo T; Osame M
Pediatr Neurol; 1992; 8(4):310-2. PubMed ID: 1388424
[TBL] [Abstract][Full Text] [Related]
12. Sarcolemmal expression of dystrophin C-terminus but reduced expression of 6q-dystrophin-related protein in two DMD patients with large deletions of the dystrophin gene.
Bittner RE; Shorny S; Ferlings R; Sperl W; Kress W; Müller CR; Cremer M; Léger JJ; Voit T
Neuromuscul Disord; 1995 Mar; 5(2):81-92. PubMed ID: 7767097
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical analysis of dystrophin-associated proteins in Becker/Duchenne muscular dystrophy with huge in-frame deletions in the NH2-terminal and rod domains of dystrophin.
Matsumura K; Burghes AH; Mora M; Tomé FM; Morandi L; Cornello F; Leturcq F; Jeanpierre M; Kaplan JC; Reinert P
J Clin Invest; 1994 Jan; 93(1):99-105. PubMed ID: 8282827
[TBL] [Abstract][Full Text] [Related]
14. Variability in clinical, genetic and protein abnormalities in manifesting carriers of Duchenne and Becker muscular dystrophy.
Bushby KM; Goodship JA; Nicholson LV; Johnson MA; Haggerty ID; Gardner-Medwin D
Neuromuscul Disord; 1993 Jan; 3(1):57-64. PubMed ID: 8329890
[TBL] [Abstract][Full Text] [Related]
15. Genetic abnormalities in Duchenne and Becker dystrophies: clinical correlations.
Medori R; Brooke MH; Waterston RH
Neurology; 1989 Apr; 39(4):461-5. PubMed ID: 2648185
[TBL] [Abstract][Full Text] [Related]
16. Dystrophin in frameshift deletion patients with Becker muscular dystrophy.
Gangopadhyay SB; Sherratt TG; Heckmatt JZ; Dubowitz V; Miller G; Shokeir M; Ray PN; Strong PN; Worton RG
Am J Hum Genet; 1992 Sep; 51(3):562-70. PubMed ID: 1496988
[TBL] [Abstract][Full Text] [Related]
17. Dystrophin analysis in the diagnosis of childhood muscular dystrophy: an immunohistochemical study of 75 cases.
Jay V; Becker LE; Ackerley C; Ray P
Pediatr Pathol; 1993; 13(5):635-57. PubMed ID: 8247961
[TBL] [Abstract][Full Text] [Related]
18. [Molecular pathology of Duchenne and Becker muscular dystrophy].
Gilgenkrantz H; Chelly J; Récan D; Chafey P; Kaplan JC
C R Seances Soc Biol Fil; 1992; 186(4):349-53. PubMed ID: 1301222
[TBL] [Abstract][Full Text] [Related]
19. [Muscular dystrophies detected by immunophenotyping and genotype analysis (mRNA and DNA)].
Lukás Z; Vojtísková M; Fajkusová L; Bednarík J; Kadanka Z; Hájek J; Hermanová M; Vohánka S; Vytopil M
Cesk Patol; 2001 Nov; 37(4):137-45. PubMed ID: 11813630
[TBL] [Abstract][Full Text] [Related]
20. Absence of correlation between utrophin localization and quantity and the clinical severity in Duchenne/Becker dystrophies.
Vainzof M; Passos-Bueno MR; Man N; Zatz M
Am J Med Genet; 1995 Sep; 58(4):305-9. PubMed ID: 8533838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]